BioNTech SE - ADR vs Centene Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Centene Corp trades at $65.13 (market cap $32.05B). The key difference: Centene Corp is the larger of the two by market cap, and Centene Corp is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | CNC | |
|---|---|---|
Market Cap | $23.31B | $32.05B |
Sector | Health | Health |
52-Week High | $119.34 | $68.72 |
52-Week Low | $83.89 | $26.17 |
Enterprise Value | $6.60B | $21.10B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →